Brief: Hyloris Pharmaceuticals Says AFT Signed Exclusive License And Supply Agreements For Commercialisation Of Maxigesic IV

Hyloris Pharmaceuticals SA

08/04/2021 06:11

April 8 (Reuters) - Hyloris Pharmaceuticals SA  HYL.BR :
    * AFT HAS SIGNED EXCLUSIVE LICENSE AND SUPPLY AGREEMENTS
WITH
MERCAPHARM SP.Z.O.O (“MERCAPHARM”) AND VIANEX SA (“VIANEX”) FOR
THE COMMERCIALISATION OF MAXIGESIC IV IN POLAND AND GREECE
RESPECTIVELY
    * ANNOUNCES FURTHER EXTENSION OF EUROPEAN FOOTPRINT OF
MAXIGESIC®
IV
    * NEW AGREEMENTS IN POLAND AND GREECE, WHICH COVER
TERRITORIES
WITH A TOTAL POPULATION OF >48.5 MILLION PEOPLE
    * AFT EXPECTS TO RECEIVE REGULATORY APPROVAL IN POLAND AND
GREECE
IN MID-2022, WITH SALES EXPECTED TO BEGIN SHORTLY THEREAFTER

Source text: https://bit.ly/3wLb1Kn
Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))